期刊文献+

氟康唑对白念珠菌菌丝相与酵母相体外药物敏感性差异比较 被引量:3

Comparative study on antifungal susceptibilities of hyphal form and yeast form of Candida albicans in vitro
下载PDF
导出
摘要 目的:以同一亲本来源的7株白念珠菌为对象,研究氟康唑对其菌丝相与酵母相抗菌活性的差异。方法:参照NCCLS M27-A方案,测定氟康唑对7株白念珠菌菌丝相与酵母相的MIC值,并比较其差异。结果:白念珠菌菌丝相与酵母相对氟康唑的敏感性不同,对菌丝相的MIC值低于酵母相。结论:氟康唑对白念珠菌菌丝相的抗菌活性强于酵母相。 Objective: Compare the differences between hyphal form and yeast form of Candida albicans on antifungal susceptibilities to fluconazole. Methods: Seven C. albicans isolates from the same strain (CA- 9, CA- 11 and CA- 13~ CA - 17) were induced to form hyphal form. The antifungal susceptibilities to fluconazole of hyphal form and yeast form of C. albicans were compared according to NCCIS M27 - A. Results: Differences of antifungal susceptibihties to fluconazole between hyphal form and yeast form of C. albicans were found, MICs to fluconazole of hyphal form of C. albicans were lower than those of yeast form. Conclusion: There are differences on antifungal susceptbilites between hyphal form and yeast form of C. albicans, the antifugal activity of fluconazole to hyphal form C. albicans is higher than that of yeast form.
出处 《中国麻风皮肤病杂志》 2006年第1期26-27,共2页 China Journal of Leprosy and Skin Diseases
基金 广东省科技计划项目(2004B33101004)
关键词 白念珠菌 酵母相 菌丝相 氟康唑 抗真菌药物敏感性试验 Candida albicans hyphal form yeast form fluconazole antifungal susceptibility test
  • 相关文献

参考文献5

二级参考文献15

  • 1White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11: 382-402.
  • 2White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.
  • 3Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 4White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1: S102-109.
  • 5Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53: 565-572.
  • 6Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4: 728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30: 281-287.
  • 7Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287.
  • 8Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS:documentation by in vitro susceptibility testing and DNA subtype analysis[J]. Clin Infect Dis, 1994,
  • 9White TC,Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient[J]. Oral Dis, 1997,3(suppl 1) : 102- 109.
  • 10White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans[J]. Antimicrob Agents Cbemother, 1997,41(7): 1488- 1494.

共引文献14

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部